Alan Nurden Shares A Study on Unusual Form of Glanzmann Thrombasthenia
Alan Nurden, Emeritus Research Director at CNRS, shared on LinkedIn:
”A detailed review of published cases of an unusual form of Glanzmann thrombasthenia where gain-of-function mutations in ITGA2B/ITGB3 genes are linked to dysregulation of RhoA activity in megakaryocytes and cytoskeletal-mediated changes in proplatelet formation and platelet release.
Such cases offer a rare insight into integrin biology.”
Read the full article here.
Article: ITGA2B/ITGB3-Related Macrothrombocytopenia Associated With Gain-of-Function Mutations in ITGA2B or ITGB3 Genes
Authors: Jiao Wu, Han Yan, Zijian Li, Yilin Zhu, Ruonan Shao, Honglei Xin, Tongyu Jia, Mengyu Ge, Lu Zhang, Suyu Jiang, Jianhua Mao, Jiansong Huang, Chao Fang, Xiaodong Xi, Xiaofeng Shi
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 18, 2026, 08:11Ardis Callie on Standardisation and Documentation of VTE Risk Assessments
-
Jan 18, 2026, 05:51Shiny K Kajal on Transfusion Medicine: From Trial and Error to Life-Saving Science
-
Jan 18, 2026, 05:40Abdul Mannan: Why Your Patient on Metformin is Losing B12
-
Jan 17, 2026, 22:13Neil Blumberg on Massive Transfusion in Trauma and Hemorrhagic Emergencies
-
Jan 17, 2026, 14:30Jecko Thachil Shares a Perspective on von Willebrand Disease
-
Jan 17, 2026, 14:16Fadi Alshrouf Explains Red Blood Cell Exchange
-
Jan 17, 2026, 14:02Abdulrahman Katib on RENOVE’s Support of Practice in VTE Longterm Managment
-
Jan 17, 2026, 13:42David McIntosh Shares a Sequel for Blood and Plasma Donors
-
Jan 17, 2026, 12:36Tomasz Brzoska on The Role of Circulating TF in Pulmonary Arterial Thrombosis